Lymphosarcoma


Note the massively enlarged cervical lymph nodes in this five-year-old ferret with lymphocytic lymphosarcoma
This eight-month-old ferret exhibits multicentric lymphoblastic lymphosarcoma with marked organ infiltration (thymus, liver, spleen).




Lymphosarcoma in the Ferret


(Article reprinted courtesy of Modern Ferret magazine.)

General.

Lymphosarcoma is the most common hematopoetic neoplasm in the ferret as well as in most other animal species, and in ferrets, the most common malignancy. While there's a fair amount of literature available on this disease, we actually know very little, and unfortunately, save few cases.

This neoplasm certainly appears to be on the rise. Practitioners and pathologists alike report an increased incidence of lymphosarcoma over the last few years - up to one to two cases weekly in some practices. While the increased incidence of lymphosarcoma and occasional clustering of cases has led to speculation of a viral cause to date, a causative agent has not been isolated.

Types of lymphosarcoma.

First, let's take a look at the varied forms that lymphosarcoma can take. There are basically two clinical presentations of lymphosarcoma in the ferret - a rapidly progressive lymphoblastic form which is most common in ferrets under 2 years of age, and a more chronic lymphocytic form which affects ferrets 5-7 years of age.

The "classic" form of lymphosarcoma, which causes marked enlargement of the peripheral nodes, is seen in older animals and has the more prolonged course of the two syndromes. In this disease, an infiltrate of small mature lymphocytes expands the peripheral and mesenteric nodes, eventually effacing nodal architecture. Late in the course of disease, neoplastic lymphocytes infiltrate visceral organs (including the liver, kidney, lungs, and spleen) resulting in organ failure and death. This disease is usually insidious, resulting in little clinical debility until extensive infiltration of visceral organs has occurred.

The lymphoblastic form, which affects ferrets from one to two years, is quite different. In this disease, large immature lymphocytes quickly infiltrate the viscera, including the thymus, spleen, liver, and many other organs. Little to no lymph node replacement is seen in these cases, a finding which results in a high rate of misdiagnosis by clinicians without extensive ferret experience. This form can take a myriad of clinical appearances depending on which organs are involved. One of the more common presentations results in dyspnea and is often diagnosed as cardiomyopathy or pneumonia. The lesion in this syndrome is actually a rapidly growing thymic mass which compresses the lungs. Less commonly, extensive hepatic infiltration by neoplastic lymphocytes may result in marked hepatic enzyme increases and icterus suggesting fulminant liver disease, and so on. Lymphoblastic lymphosarcoma should always be ruled out when dealing with any serious illness in young ferrets.

Finally, leukemic forms, in which neoplastic lymphocytes circulate within the peripheral blood, may be seen in the latter stages of either form, but are generally uncommon.

Diagnosis.

Lymphosarcoma in many cases is not an easy diagnosis. Definitive diagnosis requires interpretation of a lymph node aspirate or biopsy. While the presence of a monomorphic population of immature lymphocytes on a lymph node aspirate is highly suggestive of this disease, the opinion of a pathologist with ferret experience should be sought in all cases. Alternatively, a diagnosis may be made on biopsies of visceral organs in animals with disseminated disease, with the spleen probably yielding the highest number of positive aspirates or biopsies.

Over the last few years, a disturbing trend in diagnosis of this disease has been emerging - the interpretation of elevated lymphocyte counts as evidence of lymphosarcoma in the ferret. While many cases of lymphosarcoma may exhibit a lymphocytosis on the CBC, similar changes in the differential may be seen in any number of chronic smoldering infections, most notably gastric Helicobacter mustelae infection. The prudent practitioner requires a diagnosis by aspirate or surgical biopsy before any treatment is started.

Treatment.

Several protocols have been published for the treatment of lymphosarcoma in the ferret; however, a poor prognosis should be given to the owner before instituting any type of chemotherapy. A protocol consisting of prednisone at 1 mg/kg PO SID will cause initial clinical improvement and a marked decrease in the size of peripheral nodes, but the vast majority of these animals will return within 4-6 weeks with disseminated disease which is refractory to further prednisone treatment. The most popular aggressive protocol consists of a combination of intravenously-administered chemotherapeutic agents - vincristine, asparaginase, cyclophosphamide and doxorubricin (coupled with daily oral prednisone) over a 14 week period. Aggressive treatment appears to have a higher rate of remission than the less aggressive protocols.

Summary.

In summary, practitioners who treat ferrets are certain to encounter lymphosarcoma on a regular basis. You should remember several things when such cases are presented for evaluation and treatment. The younger the ferret at presentation, the more rapid the disease progression, and the less favorable the prognosis. Young ferrets often present with signs of heart failure or respiratory disease due to the presence of a rapidly growing thymic mass. The diagnosis of lymphosarcoma is based on the presence of a monomorphic population of blastic lymphocytes on a fine needle aspirate or surgical biopsy of a lymph node or, less commonly, a visceral organ, and NOT changes seen on a complete cell count. While prednisone may result in initial clinical improvement, more aggressive forms of chemotherapy increase the chances of inducing remission. Finally, all ferrets with lymphosarcoma should be given a poor prognosis before any treatment protocol is initiated.

References:

  1. Brown, SA. Personal communication.
  2. Brown, SA. Managing the Geriatric Ferret. In Scientific Presentations of the 61st Annual American Animal Hospital Assoc., 1994.
  3. Erdman SE et al. Malignant lymphoma in ferrets: clinical and pathological findings in 19 cases. J. Comp. Pathol 106:37-47, 1992.
  4. Fox, JG. Neoplasia. In Biology and Diseases of the Ferret. Lea & Febiger, Philadelphia, PA, 1998, pp. 275-277.
  5. Rosenthal, KR. Ferrets. In Veterinary Clinics of North America, Exotic Pet Medicine II. W.B. Saunders Company, Philadelphia, PA. 24(1):19-20, 1994.

Return to Ferret Pathology Home Page, please.
Williams@afip.mil